Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
FDA approves new type of heart failure drug from Amgen
Yahoo/AP
Thu, 04/16/15 - 09:19 am
FDA
Amgen
Corlanor
chronic heart failure
US FDA rolls out expedited access program for medical devices
Mass Device
Wed, 04/15/15 - 02:33 pm
FDA
devices
Onglyza's label should flag heart failure risks, FDA panel says
Fierce Pharma
Wed, 04/15/15 - 08:49 am
Onglya
diabetes
FDA
AstraZeneca
FDA Plans to Boost Inspectors in China Drags Over Visa Delays
WSJ Pharmalot
Tue, 04/14/15 - 12:15 pm
FDA
China
Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval?
Forbes
Mon, 04/13/15 - 11:14 am
FDA
diabetes
clinical outcomes
After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor
Fierce Biotech
Mon, 04/13/15 - 10:42 am
FDA
Medicines Company
bloodthinners
Cangrelor
Study says no good has come from FDA's action on gout drug colchicine
Fierce Pharma
Sat, 04/11/15 - 10:24 am
FDA
gout
Colcrys
Tekmira gets the FDA's OK to resume its Ebola study
Fierce Biotech
Fri, 04/10/15 - 03:47 pm
Tekmira
FDA
ebola virus
FDA: Data suggests AstraZeneca drug may increase death rate
Yahoo/Reuters
Fri, 04/10/15 - 10:44 am
AstraZeneca
FDA
Onglyza
diabetes
AZ's Onglyza has most to lose at FDA safety confab, analysts say
Fierce Pharma
Thu, 04/9/15 - 11:52 am
FDA
Onglyza
diabetes
AstraZeneca
FDA finalizes fast-track approval for medical devices
Mass Device
Thu, 04/9/15 - 09:57 am
FDA
devices
fast track
FDA Onglyza panel review set for Tuesday
Medical Marketing and Media
Wed, 04/8/15 - 05:19 pm
FDA
advisory panels
Onglyza
diabetes
AstraZeneca
Halozyme Provides Update Following Type B FDA Meeting
Yahoo
Wed, 04/8/15 - 10:44 am
Halozyme
FDA
PEGPH20
pancreatic cancer
Merck's potential HCV drug gets special FDA designation
Yahoo/AP
Wed, 04/8/15 - 10:41 am
Merck
hepatitis C
FDA
grazoprevir/elbasvir
Inside the FDA labeling fight that could upend the generics market
BioPharma Dive
Wed, 04/8/15 - 10:37 am
FDA
labeling
generics
Hatch Waxman Act
EXCLUSIVE: FDA says ReShape Medical can skip advisory panel for obesity balloon device
Mass Device
Wed, 04/8/15 - 10:18 am
FDA
ReShape Medical
advisory panels
obesity
Gilead's low-dose, high-impact HIV drug heads to the FDA
Bizjournals.com
Wed, 04/8/15 - 10:17 am
Gilead Sciences
HIV
FDA
tenofovir
emtricitabine
Hospira, soon to be part of Pfizer, spanked again by the FDA
Fierce Pharma
Tue, 04/7/15 - 12:12 pm
Hospira
Pfizer
FDA
warnings
drug manufacturing
FDA Revises Formal Meetings Guidance for PDUFA Products
FDA Law Blog
Tue, 04/7/15 - 09:53 am
FDA
PDUFA
FDA will study the impact prices have on Rx purchases
Medical Marketing and Media
Mon, 04/6/15 - 06:04 pm
FDA
drug pricing
Pages
« first
‹ previous
…
307
308
309
310
311
312
313
314
315
…
next ›
last »